Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT00301418
Title Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

malignant astrocytoma

glioblastoma

Therapies

Erlotinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.